Followers | 22 |
Posts | 2218 |
Boards Moderated | 0 |
Alias Born | 01/17/2017 |
Friday, November 17, 2017 11:37:54 PM
"Among other things, the registrant currently expects that its Liabilities and Shareholder Equity will increase by more than 30% over the last quarter, with similar increases for revenues and profitability. Since the financial statements for the quarterly period ended September 30, 2017 are not yet completed, actual results may differ materially from its current expectations."
This stock should be trading back at at least 7 cents.
The fundamentals are too good here! Positive cash flow, high revenue, low float, assets worth more than current M/C of this company. This is a no brainer.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM